Commit To Purchase SciClone Pharmaceuticals At $7.50, Earn 14% Annualized Using Options
August 12, 2015 at 11:38 AM EDT
Investors considering a purchase of SciClone Pharmaceuticals, Inc. (SCLN) shares, but cautious about paying the going market price of $8.50/share, might benefit from considering selling puts among the alternative strategies at their disposal..
